Among the population in which hepatitis E virus (HEV) infections may have a worse prognosis, HIV-infected subjects represent a high-sensitivity population because of underlying immunosuppression. Our aim was to assess the prevalence and incidence of HEV in HIV-infected patients in a national cohort and describe the viral strains.
We included HIV-infected patients recruited in the cohort of adult HIV-infected patients of the AIDS Research Network (CoRIS) in follow-up at 26 Spanish hospitals with available serum samples from the centralized BioBank in 2014 and 2015. All samples were tested for HEV IgG and IgM by ELISA (Pharmacy Enterprise© LTD, Beijing, China) and for RNA by qPCR. Samples with detectable HEV viral loads were genotyped following European HEVnet recommendations. Prevalence and incidence of HEV infection were calculated.
A total of 845 individuals were included in the study. Seven hundred and fifty-one (88.9%) were male and had a median age of 36.9 years (30.7-45.2 years). At baseline, 101 patients were positive for HEV IgG antibodies (11.9%), none had HEV IgM antibodies, and 2 presented detectable HEV RNA (0.23%). Of the 744 patients with negative HEV IgG antibody at baseline, 733 samples were available for testing during follow-up. Forty-two seroconverted for IgG, supposing a cumulative incidence of 5.7%. One patient was positive for IgM (0.13%), and 2 showed detectable HEV RNA (0.27%)., Viral strains were consistent with genotype 3f. Interestingly, in one patient, the isolated viral strain was consistent with genotype 3ra (Figure 1).
Our study found a relatively high prevalence and incidence of HEV infection in HIV-infected individuals from Spain. We identified one case of infection with the HEV 3ra genotype, the main host of which is rabbit, showing a potential zoonotic role of this emerging genotype in Spain.